SETD4-mediated KU70 methylation suppresses apoptosis

Area of Science:

• Molecular Biology
• Cell Biology
• Biochemistry

Background:

• Mammalian KU70 is a key protein involved in DNA repair and suppressing programmed cell death (apoptosis) in the cytoplasm.
• The precise regulatory mechanisms governing KU70's cytoplasmic role remain incompletely understood.

Purpose of the Study:

• To investigate the role of SET-domain-containing protein 4 (SETD4) in the regulation of KU70.
• To identify and characterize post-translational modifications of KU70 and their functional consequences.

Main Methods:

• Utilized gene silencing and overexpression techniques to manipulate SETD4 levels.
• Employed site-directed mutagenesis to assess the importance of specific SETD4 residues (Y272, Y284) and KU70 methylation site (K570).
• Analyzed protein localization and apoptosis induction using staurosporine (STS) treatment.

Main Results:

• Identified SETD4 as a methyltransferase for KU70 at lysine 570 (K570).
• Demonstrated that SETD4-mediated methylation of KU70 is essential for its anti-apoptotic function.
• Showed that SETD4 knockdown increases STS-induced apoptosis, while wild-type SETD4 overexpression suppresses it.
• Mutations in SETD4 (Y272/Y284F) or KU70 (K570R) abrogate the anti-apoptotic effects.

Conclusions:

• KU70 is a novel non-histone substrate of SETD4, with K570 methylation representing a critical post-translational modification.
• SETD4 plays a significant role in suppressing apoptosis through the methylation and subsequent cytoplasmic localization of KU70.
• This finding elucidates a new regulatory pathway controlling apoptosis and highlights the importance of SETD4 in cellular survival.